1-2 of 2
Laurens Nieuwenhuizen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Atezolizumab Consolidation in Patients with High Risk Diffuse Large B-cell Lymphoma in Complete Remission after R-CHOP

Clinical Trials & Observations
Marcel Nijland, Djamila E Issa, Johanna A. A. Bult, Dries Deeren, Gerjo A. Velders, Marten R. Nijziel, Yorick Sandberg, Vibeke KJ Vergote, Margriet Oosterveld, Rob Fijnheer, Rolf Brouwer, Rinske Boersma, Kalung Wu, Laurens Nieuwenhuizen, Joost SP Vermaat, Roel J.W. van Kampen, Wim E. Terpstra, Sylvia Snauwaert, Marjolein WM van der Poel, Eva de Jongh, Marc Durian, Leonie Strobbe, Aart Beeker, Alain PA Gadisseur, Roos Van Rijn, Otto J. Visser, Jeanette Doorduijn, Tjeerd J.F. Snijders, Matthijs H. Silbermann, Daphne de Jong, Martine E.D. Chamuleau, Rogier Mous, Mathilde Jalving, Heleen Visser-Wisselaar, Sonja Jansen van den Bergh, Gerben JC Zwezerijnen, Edwin Bremer, Mirian Brink, Arjan Diepstra, Dana A Chitu, Harry R. Koene, Josée M. Zijlstra
Journal: Blood Advances
Blood Adv bloodadvances.2024015226.
https://doi.org/10.1182/bloodadvances.2024015226
Published: 2025
Includes: Supplemental data
Journal Articles

Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study

Joline L. Saes, Marieke J. A. Verhagen, Karina Meijer, Marjon H. Cnossen, Roger E. G. Schutgens, Marjolein Peters, Laurens Nieuwenhuizen, Felix J. M. van der Meer, Ilmar C. Kruis, Waander L. van Heerde, Saskia E. M. Schols
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5025–5034.
https://doi.org/10.1182/bloodadvances.2020002740
Published: 2020
Includes: Supplemental data